Effect of sodium diclofenac on serum and tissue concentration of amoxicillin and on staphylococcal infection

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 1, 2004, Pages 52-55

  Groppo, Francisco Carlos ^a   Simões, Roberta Pessoa ^a   Ramacciato, Juliana Cama ^a   Rehder, Vera ^a   De Andrade, Eduardo Dias ^a   Mattos Filho, Thales Rocha ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Amoxicillin; Sodium diclofenac; Staphylococcal infection; Staphylococcus aureus

Indexed keywords

AGAR; AMOXICILLIN; DICLOFENAC; MANNITOL; POLYURETHAN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; CONTROLLED STUDY; CULTURE MEDIUM; DISPERSION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG TISSUE LEVEL; GRANULOMA; INOCULATION; KRUSKAL WALLIS TEST; MALE; NONHUMAN; RAT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; ANIMAL; DRUG INTERACTION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PATHOLOGY; WISTAR RAT;

AMOXICILLIN; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; DRUG INTERACTIONS; GRANULOMA; MALE; MICROBIAL SENSITIVITY TESTS; PENICILLINS; RATS; RATS, WISTAR; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 3442888585     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.52     Document Type: Article

References (33)

1. Prevot M. H., Jehl F., Rouveix B., Eur. J. Drug Metabol. Pharmacok., 22, 47-52 (1997).
2. Huisman-de-Boer J. J., van den Anker J. N., Vogel M., Goessens W. H., Schoemaker R. C., de Groot R., Antimicrob. Agents Chemother., 39, 431-434 (1995).
3. Croydon E. A. P., Sutherland R., Antimicrob. Agents Chemother., 1, 427-430 (1971).
4. Gordon R. C., Regamey C., Kirby W. M. N., Antimicrob. Agents Chemother., 1, 504-507 (1972).
5. Dajani A. S., Bawdon R. E., Berry M. C., Clin. Infect. Dis., 18, 157-160 (1994).
6. Baglie S., Groppo F. C., Mattos-Filho T. R., Braz. J. Infect. Dis., 4, 197-203 (2000).
7. Groppo F. C., Mattos-Filho T. R., Del-Fiol F. S., Biol. Pharm. Bull., 23, 1033-1035 (2000).
8. Hardman J. G., Limbird, L. E. (ed.), "Goodman & Gilman-The Pharmacological Basis of Therapeutics," Vol. 9, McGraw-Hill Co., New York, 1996.
9. Philips I., J. Antimicrob. Chemother., 27, 1-50 (1991).
10. Hsu M. C., Hsu P. W., Antimicrob. Agents Chemother., 36, 1276-1279 (1992).
11. Moore T. D., Horton R., Utrup L. J., Miller L. A., Poupard J. A., J. Clin. Microbiol., 34, 1321-1322 (1996).
12. Moran M., Curr. Med. Res. Op., 12, 268-274 (1990).
13. Mendes G. B., Franco L. M., Moreno R. A., Fernandes A. G., Muscara M. N., de Nucci G., Int. J. Clin. Pharm. Therap., 32, 131-135 (1994).
14. Davies N. M., Anderson K. E., Clin. Pharmacokinet., 33, 184-213 (1997).
15. Annadurai S., Basu S., Ray S., Dastidar S. G., Chakrabarty A. N., Indian J. Exp. Biol., 36, 86-90 (1998).
16. Koneman E. W., Allen S. D., Janda W. M., Schreckenberger P. C., Winn W. C., Jr., (ed.), "Introduction to Diagnostic Microbiology," Vol. 4, J. B. Lippincott Company, Philadelphia, 1994.
17. Lorian V., J. Clin. Microbiol., 27, 2403-2406 (1989).
18. Krauwinkel W. J. J., Kamermans-Volkers N. J., Zijtveld J., J. Chromatogr. A, 617, 334-338 (1993).
19. Charles B. G., Chulavatnatol S., Biom. Chromat., 7, 204-207 (1993).
20. Ku E. C., Lee W., Kothari H. V., Scholer D. W., Am. J. Med., 80, 18-23 (1986).
21. Friman C., Johnston C., Chew C., Scand. J. Rheum., 15, 41-46 (1986).
22. Zak O., O'reilly T., J. Antimicrob. Chemother., 31, 193-205 (1993).
23. Margarit F., Moreno-Dalmau J., Obach R., Peraire C., Pla-Delfina J. M., Eur. J. Drug Metab. Pharmacokinet., 3, 102-107 (1991).
24. Moore V. A., Irwin W. J., Timmins P., Chong S., Dando S. A., Morrison R. A., Int. J. Pharmaceut., 210, 15-27 (2000).
25. Terada T., Saito H., Mukai M., Inui K., Am. J. Physiol., 273, F706-F711 (1997).
26. Peris-Ribera J. E., Torres-Molina F., Garcia-Carbonell M. C., Aristorena J. C., Pla-Delfina J. M., J. Pharmacokinet. Biopharm., 19, 647-665 (1991).
27. Westphal J. F., Brogard J. M., Jehl F., Carbon C., Pathol. Biol. (Paris), 43, 590-595 (1995).
28. Schoenmakers R. G., Stehouwer M. C., Tukker J. J., Pharm. Res., 16, 62-68 (1999).
29. Merle-Melet M., Bresler L., Lokiec F., Dopff C., Boissel P., Dureux J. B., Antimicrob. Agents Chemother., 36, 2331-2333 (1992).
30. Chulavatnatol S., Charles B. G., Br. J. Clin. Pharmacol., 38, 274-247 (1994).
31. Reynolds J. E. F. (ed.), "Martindale. The Extra Pharmacopoeia," Vol. 31, Royal Pharmaceutical Society Press, London, 1996.
32. Ronchera C. L., Hernandez T., Peris J. E., Torres F., Granero L., Jimenez N. V., Pla J. M., Ther. Drug Monit., 15, 375-379 (1993).
33. Montgomery E. H., Kroeger D. C., Dent. Clin. North Amer., 28, 423-432 (1984).